Atlas FDA

Supartz FX and Visco-3

FDA premarket approval P980044/S050 · decided 2018-12-06

Approval details

PMA number
P980044
Supplement
S050
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Supartz FX and Visco-3
Generic name
Acid, hyaluronic, intraarticular
Applicant
Seikagaku Corp.
Date received
2018-11-06
Decision date
2018-12-06
Days to decision
30 days
Decision code
OK30
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Tokyo
Statement
Installation of two new sterility test isolators and a new laminar flow hood, as well as associated changes involving relocation of various sterility and bioburden testing activities and equipment.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HADGEL, 4 GRAM/SYRINGE (K011544)Seikagaku Corp.2001-08-15